Skip to main content
  • 7 Nikola Pašić Sq., 4th Fl., 11000 Belgrade
  • info@smj.rs

logo LKS

Case report

Laparoscopic approach to the treatment of inflammatory myofibroblastic tumor of the spleen, case report and literature review

Nikola Grubor1, Dragan Erić2, Ivana Pavlović1, Goran Tasić3, Slavko Matić1
  • Clinic for Digestive Surgery, Clinical Center of Serbia, Belgrade, Serbia
  • Health Care Clinic, Belgrade, Serbia
  • Stefan Visoki General Hospital, Smederevska Palanka, Serbia

ABSTRACT

Introduction: Benign tumors of the spleen are a rare condition. Their pathogenesis and clinical presentation represent a diagnostic and surgical challenge in the sense of establishing the correct diagnosis and selecting the appropriate surgical approach.

Case report: In our paper we are presenting a 45-year-old female patient who was initially tested and examined because of nonspecific complaints manifesting as occasional pain in the left upper quadrant of the abdomen. The values of the laboratory findings were within the reference range and preoperative radiological diagnostics indicated the existence of a mass in the spleen which had the features of a tumor. Based on the preoperative diagnostic finding we decided to perform laparoscopic splenectomy. Postoperative recovery was without adverse events, and the patient was prescribed the necessary vaccination and antibiotic prophylaxis.

Conclusion: Myofibroblastic tumor of the spleen represents, as far as its origin is concerned, a mystery, with its very limited and nonspecific presentation of symptoms, which is why each individual case must be approached seriously. Laparoscopy has a very important role in the treatment of this disease, bearing in mind all the advantages of a minimally invasive approach over open surgery.


INTRODUCTION

Inflammatory myofibroblastic tumor of the spleen is a rare benign disease of unknown pathogenesis. It is most commonly diagnosed as an incidental finding within diagnostic procedures [1].

According to the data from existing literature, most patients diagnosed with this disease are of middle age, and there is a somewhat higher frequency of incidence in female patients. Symptoms can vary, from abdominal pain or discomfort in the abdomen to fever and splenomegaly [2],[3].

Radiological diagnostics can provide approximate data as to the existence of a hypoechogenic mass in the spleen, with or without calcifications. The reliability of radiological diagnostics is not sufficient, which is why a definite diagnosis is established by means of a histopathological examination [4],[5].

Splenectomy represents the only curative modality of treatment. As is already known, laparoscopic splenectomy represents the golden standard in treating almost all splenic diseases. Because of numerous advantages over open (classic) splenectomy, primarily a lesser number of complications, better visualization, lesser intraoperative blood loss, shorter postoperative hospitalization, quicker recovery, and, finally, a better cosmetic effect, priority should be given to laparoscopic splenectomy [6]. Clinical follow-up of surgically treated patients should, nevertheless, be carried out [7].

In our paper, we present an operating technique and laparoscopic splenectomy, itself, as a safe, efficient and easily applicable modality of treating inflammatory myofibroblastic tumor of the spleen.

CASE REPORT

 We present a female patient, aged 45 years, with a body mass index (BMI) of 24.7 kg/m2 , without comorbidities. Diagnostic testing of this patient started due to nonspecific pain in the upper left quadrant of the abdomen, which had begun three months prior to hospitalization at our clinic. Ultrasonographic (US) examination of the abdomen showed a suspect tumorous mass in the spleen. Upon admission to our clinic diagnostics was completed with computerized tomography (CT) of the abdomen, which verified the existence of a hypoechogenic mass in the spleen, with a craniocaudal diameter of 62 mm, and a transverse diameter of 58 mm, which had the characteristic of a tumor of the spleen (Figure 1).

f01

Figure 1. Image of the tumor of the spleen on preoperative CT examination

Laboratory results, as well as tumor marker values (CEA, AFP, CA 19-9), were within the reference range. Based on the preoperative diagnostics we decided to perform a laparoscopic splenectomy.

After being put under general endotracheal anesthesia (GETA), the patient was placed in the right lateral position and the so-called hanging spleen technique was applied. After that, artificial pneumoperitoneum was created with the aid of a Veress needle. The procedure further dictates the placement of four working ports which are used to introduce different laparoscopic instruments during the surgical procedure. A port of 12 mm in diameter is placed laterally left to the anterior axillary line, above the anterior superior iliac spine, since it is used to introduce the stapler for cutting the splenic hilum and removing the splenic specimen at the end of the operation. The camera is introduced through the port which is located left and laterally to the navel. The third port is placed subxiphoidally, while the fourth one should be below the 12th rib at the level of the middle or posterior axillary line. Inspection of the abdomen resulted in a normal finding, upon which we commenced with splenectomy. First, we cut the splenic ligaments with a laparoscopic ultrasonic dissector (Laparoscopic Harmonic Scalpel, Ethicon Endo-Surgery, Inc, Cincinnati, Ohio, USA), which we also used for the short gastric blood vessels. As an option for the hemostatic technique for vascular elements of the splenic hilum we applied the endovascular stapler (Endo GIA, Autosuture, Covidien, Mansfield, MA, USA) (Figure 2). Upon splenectomy, the spleen was placed in a polyurethane extraction bag, the spleen was then morcellated with surgical instruments and the fragments were then removed from the abdomen. The splenic specimen was sent for definitive histopathological verification. At the end of the procedure we placed a drain in the left subphrenium, let out the gas, and reconstructed the sites of the port incisions by anatomical layers.

f02

Figure 2. Intraoperative hemostatic technique (endovascular stapler)

There were no complications during postoperative recovery, the abdominal drain was removed on the second postoperative day and the patient was discharged from hospital on the third postoperative day. Postoperatively, the patient received prophylactic antibiotic therapy as well as pneumococcal, meningococcal and Hib vaccines, as recommended by current guidelines in literature for preventing and treating overwhelming postsplenectomy infection (OPSI).

The histopathological finding showed a definite diagnosis of inflammatory myofibroblastic tumor of the spleen.

Microscopic description: clearly delimited tumefaction without a capsule, composed of a mixed cell population, comprising multiplied stromal elements, especially elongated fibroblastoid and myofibroblastoid cells, multiplied blood vessels, as well as a mixed lymphoid infiltration within which dominantly lymphocytic and sparsely plasmacytic elements can be seen, with a very few granulocytes and histocytes. Sporadically, large cells with hyperchromatic nuclei are visible, without significant nuclear atypia or pleomorphism. In individual areas, sporadic storiform histological organization is evident, and areas of hypocellularity are rare. There is no evidence of tumorous necrosis or of significant mitotic activity.

The patient was monitored and controlled after the surgical procedure. A month after the operation, a follow-up US of the abdomen was performed and a normal finding was obtained; 6 months after the operation, magnetic resonance imaging (MRI) was performed, which also produced a normal finding; subsequently, a follow-up MRI of the abdomen was performed every 12 months, and laboratory parameters were monitored at each check-up (every three months).

DISCUSSION

This disease was first described by Cotelingam and Jaffe in 1984, and since then 114 cases have been described in the world [2],[3].

Inflammatory pseudotumor can occur in various organs, including the eye, the lungs, the digestive tract, the spleen. Generally speaking, benign tumors of the spleen are a rare, with an incidence of 0.007% in the general population, while inflammatory pseudotumor of the spleen has an even lesser frequency [3],[5].

The pathogenesis of this disease remains unknown. There are several factors which could be potential causes of inflammatory pseudotumor of the spleen: immunological disorders, neoplastic processes, bacterial infections, vascular causes; and there have been several described cases indicating a possible link with the Epstein-Barr viral infection [5],[8],[9].

There is no typical clinical presentation of this disease. Symptomatology may be absent or may present in the form of nonspecific complaints, nausea, bloating, discomfort, fever, splenomegaly and abdominal pain, or in the form of symptoms that indicate the presence of malignancy. The disease is diagnosed as an incidental finding within diagnostic procedures carried out for other diseases [3],[8],[10]. Laboratory analyses are usually within the reference range, with individual reported cases of hypercalcemia and hypergammaglobulinemia [11].

In the case we are presenting, the symptomatology was uncharacteristic, with occasional discomfort and nonspecific pain in the upper left hypochondrium of the abdomen.

Radiological diagnostics is not reliable in establishing a definite diagnosis of this disease. Available data confirm that this is a hypoechogenic mass in the spleen, which may or may not contain calcifications [10]. Speaking in terms of differential diagnosis, such masses in the spleen may indicate other diseases of the spleen, such as abscess, hemangioma, lymphoproliferative diseases, and hematoma [12],[13].

From our experience of many years in treating diseases of the spleen, and also based on the current principles of treating patients suffering from benign tumors of the spleen, we do not advocate preoperative histopathological diagnostics, which is achieved through fine needle aspiration, due to the many disadvantages of this procedures and based on our belief that splenectomy is the only correct modality of treatment [14],[15].

Splenectomy, laparoscopic or classic, is, at present, the only modality of treating this disease. Since laparoscopic splenectomy is considered to be the golden standard in treating almost all splenic diseases, it should definitely be the first choice, before open surgery, due to the generally well known positive results that are achieved with the application of this surgical approach [12].

Since our hospital has the appropriate facilities and equipment, as well as a team of experts trained for applying the minimally invasive approach in treating splenic diseases, we had no dilemma when selecting the operating technique in this case.

After splenectomy, long-term results are good, and cases of recidivation or metastasizing have not been recorded. Nevertheless, clinical follow-up is recommended, since death of some patients with inflammatory tumor of the liver has been recorded, and some authors connect this outcome to the underlying illness [16].

CONCLUSION

 Myofibroblastic tumor of the spleen is of unknown origin, the presentation of its symptoms is very limited and nonspecific, which is why each individual case must be approached very seriously. The unreliability of preoperative radiological diagnostics in establishing a diagnosis of this disease, despite the application of modern diagnostic techniques, requires a serious multidisciplinary approach in its treatment, which is why the laparoscopic approach, with all of its advantages (as compared to open surgery), represents an efficient and safe treatment modality, with better short-term and long-term results than the classic surgical approach.

  • Conflict of interest:
    None declared.

Informations

December 2020

Pages 143-148
  • Keywords:
    spleen, splenectomy, laparoscopy, benign tumor
  • Received:
    06 October 2020
  • Revised:
    31 October 2020
  • Accepted:
    03 November 2020
  • Online first:
    25 December 2020
  • DOI:
  • Cite this article:
    Grubor N, Erić D, Pavlović I, Tasić G, Matić S. Laparoscopic approach to the treatment of inflammatory myofibroblastic tumor of the spleen, case report and literature review. Serbian Journal of the Medical Chamber. 2020;1(2):143-8. doi: 10.5937/SMCLK2002143G
Corresponding author

Nikola Grubor
Clinic for Digestive Surgery, Clinical Center of Serbia
6 Koste Todorovića Street, 11000 Belgrade, Serbia
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.


1. Georgia M, Rady K, Prince HM. Inflammatory Pseudotumor of the Spleen. Hematol Rep. 2015;7(2):5905.[CROSSREF]

2. Cotelingam JD, Jaffe ES. Inflammatory pseudotumor of the spleen. Am J Surg Pathol. 1984 May;8(5):375-80.[CROSSREF]

3. Ma ZH, Tian XF, Ma J, Zhao YF. Inflammatory pseudotumor of the spleen: A case report and review of published cases. Oncol Lett. 2013;5(6):1955-7.[CROSSREF]

4. Siewert B, Millo NZ, Sahi K, Sheiman RG, Brook OR, Sun MRM, et al. The Incidental Splenic Mass at CT: Does It Need Further Work-up? An Observational Study. Radiology. 2018;287(1):156–66.[CROSSREF]

5. Toumi O, Ammar H, Chhaidar A, Gupta R, Korbi I, Nasr M, et al. Inflammatory Pseudotumor of Spleen: A Case Report. Clin Surg. 2017;2:1679.[CROSSREF]

6. Misiakos EP, Bagias G, Liakakos T, Machairas A. Laparoscopic splenectomy: Current concepts. World J Gastrointest Endosc. 2017;9(9):428-37.[CROSSREF]

7. Fieldman L, Munshi A, Al-Mahroos M, Fried G. The Spleen. Maingot’s abdominal operations. 13th ed. New York: McGraw-Hill; 2019. p. 1239-49.

8. Chatzoulis G, Passos ID, Ioannidis K, Georgopoulos C, Spyridopoulos P. Inflammatory Pseudotumor of the Spleen. Hellenic J Surg. 2018;90(1):52–4.[CROSSREF]

9. Noguchi H, Kondo H, Kondo M, Shiraiwa M, Monobe Y. Inflammatory Pseudotumor of the Spleen: A Case Report. Jpn J Clin Oncol. 2000;30(4):196–203.[CROSSREF]

10. Ding Y, Yang HY, Zhang D, Guo F, Wang JX, Li YP, et al. Diagnosis and treatment of inflammatory myofibroblastoma in children and adolescents. Chin Med J. 2019;5;132(9):1110-2.[CROSSREF]

11. Hsu CW, Lin CH, Yang TL, Chang HT. Splenic inflammatory pseudotumor mimicking angiosarcoma. World J Gastroenterol. 2008;14(41):6421-4. [CROSSREF]

12. Adrian PE, Eduardo TM. Spleen. In: Brunicardi FC, Andersen DK, Billiar TR, Dunn DL, Hunter JG, editors. Schwartz’s Principles of Surgery. Tenth edition. ed. New York: McGraw-Hill Education; 2015. p. xviii.

13. Wang B, Xu X, Li YC. Inflammatory myofibroblastic tumor of the spleen: a case report and review of the literature. Int J Clin Exp Pathol. 2019 May 1;12(5):1795-1800.[HTTP]

14. Milosavljević V, Tadić B, Grubor N, Erić D, Matić S. Laparoscopic Vs. Open Surgery in Management of Benign Neoplasms of Spleen—Single Institution Experience. Indian J of Surg. 2020;3:355–9.[CROSSREF]

15. Gonzalez-Urquijo M, Rodarte-Shade M, Gil-Galindo G. Splenic Primary Solid Tumors: Does a Preoperative Histopathology Diagnosis Really Matter? The American Surgeon. 2020; 3134820951480.[CROSSREF]

16. Wang Z, Zhao X, Li K, Yao W, Dong K, Xiao X, et al. Analysis of clinical features and outcomes for inflammatory myofibroblastic tumors in China: 11 years of experience at a single center. Pediatr Surg Int. 2016;32(3):239-43.[CROSSREF]


REFERENCES

1. Georgia M, Rady K, Prince HM. Inflammatory Pseudotumor of the Spleen. Hematol Rep. 2015;7(2):5905.[CROSSREF]

2. Cotelingam JD, Jaffe ES. Inflammatory pseudotumor of the spleen. Am J Surg Pathol. 1984 May;8(5):375-80.[CROSSREF]

3. Ma ZH, Tian XF, Ma J, Zhao YF. Inflammatory pseudotumor of the spleen: A case report and review of published cases. Oncol Lett. 2013;5(6):1955-7.[CROSSREF]

4. Siewert B, Millo NZ, Sahi K, Sheiman RG, Brook OR, Sun MRM, et al. The Incidental Splenic Mass at CT: Does It Need Further Work-up? An Observational Study. Radiology. 2018;287(1):156–66.[CROSSREF]

5. Toumi O, Ammar H, Chhaidar A, Gupta R, Korbi I, Nasr M, et al. Inflammatory Pseudotumor of Spleen: A Case Report. Clin Surg. 2017;2:1679.[CROSSREF]

6. Misiakos EP, Bagias G, Liakakos T, Machairas A. Laparoscopic splenectomy: Current concepts. World J Gastrointest Endosc. 2017;9(9):428-37.[CROSSREF]

7. Fieldman L, Munshi A, Al-Mahroos M, Fried G. The Spleen. Maingot’s abdominal operations. 13th ed. New York: McGraw-Hill; 2019. p. 1239-49.

8. Chatzoulis G, Passos ID, Ioannidis K, Georgopoulos C, Spyridopoulos P. Inflammatory Pseudotumor of the Spleen. Hellenic J Surg. 2018;90(1):52–4.[CROSSREF]

9. Noguchi H, Kondo H, Kondo M, Shiraiwa M, Monobe Y. Inflammatory Pseudotumor of the Spleen: A Case Report. Jpn J Clin Oncol. 2000;30(4):196–203.[CROSSREF]

10. Ding Y, Yang HY, Zhang D, Guo F, Wang JX, Li YP, et al. Diagnosis and treatment of inflammatory myofibroblastoma in children and adolescents. Chin Med J. 2019;5;132(9):1110-2.[CROSSREF]

11. Hsu CW, Lin CH, Yang TL, Chang HT. Splenic inflammatory pseudotumor mimicking angiosarcoma. World J Gastroenterol. 2008;14(41):6421-4. [CROSSREF]

12. Adrian PE, Eduardo TM. Spleen. In: Brunicardi FC, Andersen DK, Billiar TR, Dunn DL, Hunter JG, editors. Schwartz’s Principles of Surgery. Tenth edition. ed. New York: McGraw-Hill Education; 2015. p. xviii.

13. Wang B, Xu X, Li YC. Inflammatory myofibroblastic tumor of the spleen: a case report and review of the literature. Int J Clin Exp Pathol. 2019 May 1;12(5):1795-1800.[HTTP]

14. Milosavljević V, Tadić B, Grubor N, Erić D, Matić S. Laparoscopic Vs. Open Surgery in Management of Benign Neoplasms of Spleen—Single Institution Experience. Indian J of Surg. 2020;3:355–9.[CROSSREF]

15. Gonzalez-Urquijo M, Rodarte-Shade M, Gil-Galindo G. Splenic Primary Solid Tumors: Does a Preoperative Histopathology Diagnosis Really Matter? The American Surgeon. 2020; 3134820951480.[CROSSREF]

16. Wang Z, Zhao X, Li K, Yao W, Dong K, Xiao X, et al. Analysis of clinical features and outcomes for inflammatory myofibroblastic tumors in China: 11 years of experience at a single center. Pediatr Surg Int. 2016;32(3):239-43.[CROSSREF]

1. Georgia M, Rady K, Prince HM. Inflammatory Pseudotumor of the Spleen. Hematol Rep. 2015;7(2):5905.[CROSSREF]

2. Cotelingam JD, Jaffe ES. Inflammatory pseudotumor of the spleen. Am J Surg Pathol. 1984 May;8(5):375-80.[CROSSREF]

3. Ma ZH, Tian XF, Ma J, Zhao YF. Inflammatory pseudotumor of the spleen: A case report and review of published cases. Oncol Lett. 2013;5(6):1955-7.[CROSSREF]

4. Siewert B, Millo NZ, Sahi K, Sheiman RG, Brook OR, Sun MRM, et al. The Incidental Splenic Mass at CT: Does It Need Further Work-up? An Observational Study. Radiology. 2018;287(1):156–66.[CROSSREF]

5. Toumi O, Ammar H, Chhaidar A, Gupta R, Korbi I, Nasr M, et al. Inflammatory Pseudotumor of Spleen: A Case Report. Clin Surg. 2017;2:1679.[CROSSREF]

6. Misiakos EP, Bagias G, Liakakos T, Machairas A. Laparoscopic splenectomy: Current concepts. World J Gastrointest Endosc. 2017;9(9):428-37.[CROSSREF]

7. Fieldman L, Munshi A, Al-Mahroos M, Fried G. The Spleen. Maingot’s abdominal operations. 13th ed. New York: McGraw-Hill; 2019. p. 1239-49.

8. Chatzoulis G, Passos ID, Ioannidis K, Georgopoulos C, Spyridopoulos P. Inflammatory Pseudotumor of the Spleen. Hellenic J Surg. 2018;90(1):52–4.[CROSSREF]

9. Noguchi H, Kondo H, Kondo M, Shiraiwa M, Monobe Y. Inflammatory Pseudotumor of the Spleen: A Case Report. Jpn J Clin Oncol. 2000;30(4):196–203.[CROSSREF]

10. Ding Y, Yang HY, Zhang D, Guo F, Wang JX, Li YP, et al. Diagnosis and treatment of inflammatory myofibroblastoma in children and adolescents. Chin Med J. 2019;5;132(9):1110-2.[CROSSREF]

11. Hsu CW, Lin CH, Yang TL, Chang HT. Splenic inflammatory pseudotumor mimicking angiosarcoma. World J Gastroenterol. 2008;14(41):6421-4. [CROSSREF]

12. Adrian PE, Eduardo TM. Spleen. In: Brunicardi FC, Andersen DK, Billiar TR, Dunn DL, Hunter JG, editors. Schwartz’s Principles of Surgery. Tenth edition. ed. New York: McGraw-Hill Education; 2015. p. xviii.

13. Wang B, Xu X, Li YC. Inflammatory myofibroblastic tumor of the spleen: a case report and review of the literature. Int J Clin Exp Pathol. 2019 May 1;12(5):1795-1800.[HTTP]

14. Milosavljević V, Tadić B, Grubor N, Erić D, Matić S. Laparoscopic Vs. Open Surgery in Management of Benign Neoplasms of Spleen—Single Institution Experience. Indian J of Surg. 2020;3:355–9.[CROSSREF]

15. Gonzalez-Urquijo M, Rodarte-Shade M, Gil-Galindo G. Splenic Primary Solid Tumors: Does a Preoperative Histopathology Diagnosis Really Matter? The American Surgeon. 2020; 3134820951480.[CROSSREF]

16. Wang Z, Zhao X, Li K, Yao W, Dong K, Xiao X, et al. Analysis of clinical features and outcomes for inflammatory myofibroblastic tumors in China: 11 years of experience at a single center. Pediatr Surg Int. 2016;32(3):239-43.[CROSSREF]


© All rights reserved. Medical Chamber of Serbia.

To top